Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Mediplex Turnersville south jersey radiology

Members of private equity-backed radiology group sell imaging center at a 1,300% profit

The buyer is Port Washington, Pennsylvania-based Mediplex Property Group, which is now leasing the center back to South Jersey Radiology Associates. 

RadNet CEO Howard Berger

RadNet is sitting on almost $700M in cash. CEO Howard Berger, MD, discusses how he plans to deploy it

He discussed the Los Angeles-based imaging center operator's growth strategy during the Jefferies 2024 Global Healthcare Conference. 

Connecticut Breast Imaging

3 radiology providers tout new outpatient center openings across 3 states

Private equity-backed SimonMed has opened a new outpost in Houston, while Connecticut Breast Imaging and the American Oncology Network also are growing. 

Thumbnail

Radiology stakeholders weigh in on FTC’s exploration of how ‘corporate greed’ is impacting the specialty

The Federal Trade Commission, Department of Justice, and Health and Human Services recently launched an inquiry into private equity and other corporations’ “increasing control over healthcare." 

healthcare money economics dollar stethoscope acquire merger

Private equity in healthcare: Cardiologists, government officials and advocacy groups share their perspective

The FTC and other federal agencies launched a public inquiry to see how physicians, patients and other stakeholders felt about the rising influence of private equity in healthcare. Based on the public comments available online, many in the industry are concerned about the trend's long-term impact on patient care. 

Telix Pharmaceuticals

PET imaging-agent developer Telix seeks to raise $200M through initial public offering

The Australian radiopharma firm's financial maneuver comes amid its roll out of the first targeted positron emission tomography agent for kidney cancer. 

Eko Health, the California-based healthcare technology company known for its advanced stethoscopes, has received U.S. Food and Drug Administration (FDA) approval for a new artificial intelligence (AI) offering designed to detect low ejection fraction (EF).

Eko Health raises $41M to expand footprint of its AI-powered stethoscopes

Now that the company has gained FDA approval for multiple algorithms, Eko Health aims to reach as many patients as possible with its AI-powered devices.

Employee retention staffing hiring

Neuralink growing rapidly following successful human trial

Elon Musk's Neuralink is attracting talent and investors as it moves forward with plans to implant devices into patients who can't use their limbs.